NASDAQ: CDLX
Cardlytics Inc Stock

$1.18-0.01 (-0.84%)
Updated Dec 10, 2025
CDLX Price
$1.18
Fair Value Price
N/A
Market Cap
$63.79M
52 Week Low
$0.85
52 Week High
$4.05
P/E
-0.58x
P/B
-13.56x
P/S
0.52x
PEG
N/A
Dividend Yield
N/A
Revenue
$251.18M
Earnings
-$110.83M
Gross Margin
44.4%
Operating Margin
-41.15%
Profit Margin
-44.1%
Debt to Equity
-63.25
Operating Cash Flow
-$741k
Beta
2.56
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CDLX Overview

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CDLX's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Advertising Agency

Industry Rating
C
CDLX
Ranked
#24 of 27

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$21.94A
$20.45A
$72.05B
View Top Advertising Agency Stocks

Be the first to know about important CDLX news, forecast changes, insider trades & much more!

CDLX News

Overview

Due Diligence Score

Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CDLX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CDLX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CDLX is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CDLX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CDLX due diligence checks available for Premium users.

Valuation

CDLX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.58x
Industry
-24.67x
Market
46.23x

CDLX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-13.56x
Industry
2.33x

CDLX's financial health

Profit margin

Revenue
$52.0M
Net Income
-$72.7M
Profit Margin
-139.7%
CDLX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
CDLX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$292.8M
Liabilities
$297.5M
Debt to equity
-63.25
CDLX's short-term assets ($140.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CDLX's long-term liabilities ($173.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CDLX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CDLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$1.8M
Investing
-$4.5M
Financing
-$12.0k
CDLX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CDLX vs Advertising Agency Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CDLXD$63.79M-0.84%-0.58x-13.56x
FLNT$63.91M-3.65%-2.09x2.96x
MCHX$72.01M-2.38%-14.91x2.25x
TZOOC$77.29M+3.51%10.40x-9.54x
SDM$49.03M0.00%23.13x7.22x

Cardlytics Stock FAQ

What is Cardlytics's quote symbol?

(NASDAQ: CDLX) Cardlytics trades on the NASDAQ under the ticker symbol CDLX. Cardlytics stock quotes can also be displayed as NASDAQ: CDLX.

If you're new to stock investing, here's how to buy Cardlytics stock.

What is the 52 week high and low for Cardlytics (NASDAQ: CDLX)?

(NASDAQ: CDLX) Cardlytics's 52-week high was $4.05, and its 52-week low was $0.85. It is currently -70.83% from its 52-week high and 38.5% from its 52-week low.

How much is Cardlytics stock worth today?

(NASDAQ: CDLX) Cardlytics currently has 54,056,548 outstanding shares. With Cardlytics stock trading at $1.18 per share, the total value of Cardlytics stock (market capitalization) is $63.79M.

Cardlytics stock was originally listed at a price of $13.37 in Feb 9, 2018. If you had invested in Cardlytics stock at $13.37, your return over the last 7 years would have been -91.17%, for an annualized return of -29.3% (not including any dividends or dividend reinvestments).

How much is Cardlytics's stock price per share?

(NASDAQ: CDLX) Cardlytics stock price per share is $1.18 today (as of Dec 10, 2025).

What is Cardlytics's Market Cap?

(NASDAQ: CDLX) Cardlytics's market cap is $63.79M, as of Dec 11, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cardlytics's market cap is calculated by multiplying CDLX's current stock price of $1.18 by CDLX's total outstanding shares of 54,056,548.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.